2. Introduction C2 Biotechnologies, LLC Formed for profit, 2006 DoE SBIR Funded Strong background in molecular biology Low overhead costs Using biotechnology to improve the quality of life 7/19/2011 2
3. Project Summary Clone enzyme activities that convert furfural and derivatives into plastic. Combine enzyme activities into 1 protein (Plasticzyme). Offer Plasticzymeas new industrial enzyme for cellulosic pre-fermentation treatment alternative. 7/19/2011 3
4. Problem Cellulosic biomass pre-treatment produces fermentation (yeast) inhibitors. Removal of fermentation inhibitors required but cost time and money. Converting fermentation inhibitors into plastic creates new product and improves process economics. 7/19/2011 4
10. Key Personnel Dr. Cosenza will oversee team Dr. Cosenza Research Assistant 1 Research Assistant 2 Research Assistant 3 7/19/2011 10
11. Evaluation Project will be evaluated in the form of milestones with go or no go decision points. Definable actions with anticipated outcomes form basis for project decisions-i.e. chemistry produces bio-plastic…go to next step. Written approval from sponsor required for project progression 7/19/2011 11
12. Return on Investment Option to license technology Commercial sources of “Plasticzyme” not available Bio-plastic market growing Global market at $2.7 billion* *E-zine: Environmental Leader, “Global BioplasticsMarket to Surpass $11 Billion by 2015”, posted 2/3/2011 7/19/2011 12
13. Contact Information 7/19/2011 13 Dr. Larry Cosenza C2 Biotechnologies, LLC 4663 Route 9G Germantown, NY 12526 Telephone: (518)537-7678 E-mail: lcosenza@c2biotechnologies.com